30 closest matches · ranked by relevance
Contraception
Primary: Rates of Uterine Perforation — 0 Number of cases
Pregnancy, Unplanned · Pregnancy; Accident
Primary: Number of Participants With Pregnancy Following Emergency Contraception — 0; 0; 0; 6 Participants
Contraceptive Usage
Primary: The Primary Outcome is LNG-IUD Usage Six Months Following Enrollment. — 85.2; 62.9 percentage of participants — p=0.05
Contraception
Primary: The Ease of IUD Insertion as Rated by the Provider Using a 100mm Visual Analog Scale (VAS). — 24; 29 mm
Contraception
Primary: Successful Retention of IUD — 7 participants
Asherman Syndrome
Primary: the AFS Score at Second-look Hysteroscopy — 6.5; 8 Units on a scale — p=<0.05
Contraception
Primary: The Primary Outcome Measure is Effectiveness as Calculated by the Pearl Index — 0.53; 1.41; 0.00 Pearl Index
Contraception
Primary: Retention Rate — 55; 75 percentage of randomized subjects — p=0.4003
Contraception
Primary: Use of the IUD for Contraception at Six Months — 49; 51 participants — p=0.24
Intrauterine Device Expulsion
Primary: Number of Participants With Expulsion of IUD — 54; 0 Participants
Contraception
Primary: IUD Expulsion Rate — 20; 7 Participants
Contraception
Primary: Pearl Index up to 3 Years — 0.33; 0.31 Pregnancies per 100 women years
Pain Due to Intrauterine Contraceptive Device
Primary: Pain With Intrauterine Device (IUD) Placement — 54; 33 mm
Unplanned Pregnancy
Primary: IUD Expulsion — 11 Participants
Pain
Primary: Patient Perceived Pain on a 100-point Visual Analogue Scale. — 0.5; 0.8; 5.8; 5.9 units on a scale
Contraception
Primary: Expulsion Rate — 9 participants
Contraception
Primary: Pearl Index — 0.17; 0.82; 0.00 Number per 100 women years
Contraception
Primary: IUD Usage Rate at 6 Months — 43; 39 participants
Contraception
Primary: Provider Perceived Ease of Insertion on a 100-point Visual Analogue Scale (VAS) — 25.1; 27.4 units on a scale — p=0.64
Intrauterine Device Expulsion · Medical Abortion · Induced Abortion
Primary: Percentage of Women With Expulsion of an Intrauterine Device (IUD) Placed After Medical Abortion. — 4 percentage of participants
HIV
Primary: Participants With Detectable Genital Tract HIV Ribonucleic Acid (RNA) Viral Load (VL) — 18; 23; 10; 7 Participants — p=0.66
Intrauterine Devices · Cesarean Section
Primary: IUD Use — 32; 40 participants
Pregnancy
Primary: Use of an Effective Method of Contraception at 6 Months After Requesting Emergency Contraception — 9; 13 participants
Contraception
Primary: Provider Perceived Ease of Insertion on a 100 Point Visual Analogue Scale — 21; 21 units on a scale
Contraception
Primary: Percentage of Participants Reporting a Pregnancy — 0; 0.3 % of participants reporting pregnancy
Contraceptive Devices, Intrauterine · Education, Medical
Primary: Insertion Score Before and Immediately After Initial Practice (Same Day), and 3 Months After Initial Practice — 61.5; 67.5; 82.5; 83 Percent of tasks performed correctly
Pain
Primary: Pain During IUD Insertion at Various Time Points (See Description for Time Points) — 35.4; 34.3; 55.5; 51.6 units on a 100 mm visual analogue scale
Intrauterine Adhesion
Primary: Number of Participants With Adhesion Reformation (American Fertility Society Score of Greater Than 0) 8 Weeks Later After the Index Surgery — 21; 38 Participants — p=0.012
Intrauterine Device (IUD) · Abnormal Uterine Bleeding
Primary: Patient-perceived Pain — 3; 4 score on a scale — p=0.21
Contraception · Pain
Primary: Pain Control With IUD Insertion — 3.606; 3.088; 2.83; 3.382 units on a scale